Terry Murdock
Chief Operating Officer at G1 THERAPEUTICS, INC.
Net worth: 400 043 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jack Bailey | M | 59 | 4 years | |
Monica Thomas | F | - | 1 years | |
W. Staub | M | 61 | 8 years | |
Ari Bousbib | M | 63 | 8 years | |
Garry Nicholson | M | 69 | 6 years | |
Jacks Lee | M | 60 | 2 years | |
James Berkshire | M | 51 | 7 years | |
Alicia Secor | F | 62 | 3 years | |
Norman Sharpless | M | 57 | 2 years | |
John Danhakl | M | 67 | 8 years | |
Cynthia Flowers | F | 64 | 6 years | |
William C. Roberts | M | 54 | 3 years | |
Todd Sisitsky | M | 52 | 8 years | |
John Leonard | M | 66 | 9 years | |
Jim Fasano | M | 54 | 8 years | |
Glenn Muir | M | 65 | 9 years | |
Andrew Beelen | M | - | - | |
Andrew Perry | M | 51 | 3 years | |
Trudy Stein | F | - | 8 years | |
Rajesh K. Malik | M | 65 | 10 years | |
Mark Avagliano | M | 48 | 5 years | |
Michael Stibilj | M | 55 | 7 years | |
John Umstead | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jay C. Strum | M | - | 11 years | |
Seth A. Rudnick | M | 75 | 7 years | |
Christy Shaffer | M | 66 | 6 years | |
Mark Velleca | M | 60 | 9 years | |
Glenn C. Rice | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
Jeff Macdonald | M | - | 3 years | |
Darcie Peck | F | 66 | 14 years | |
Andrew Witty | M | 59 | 3 years | |
Marla Kessler | F | - | - | |
Tyrell J. Rivers | M | 51 | 1 years | |
James Hanson | M | 52 | - | |
Gregory J. Mossinghoff | M | - | 3 years | |
James Erlinger | M | 65 | 2 years | |
Fred Eshelman | M | 76 | 6 years | |
Ronald Rittenmeyer | M | 76 | 6 years | |
Willie Deese | M | 68 | 4 years | |
Richard L. Love | M | 81 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 10 years |
Shannon Morris | M | 54 | 3 years | |
Donna Kralowetz | F | 53 | 2 years | |
Melissa Beelen | F | - | 5 years | |
Richie Etwaru | M | - | 3 years | |
Tal Rosenberg | M | - | - | |
Soma Gupta | F | - | 1 years | |
David D. Elks | M | - | 3 years | |
Shannon Morris | M | - | 3 years | |
Joanne Zellner | F | - | 1 years | |
Lisa van Capelle | F | - | 12 years | |
Ostra Jewell | F | - | - | |
Jason S. Fisherman | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Mark E. Watson | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Alexander D. Smith | M | - | 6 years | |
John Demaree | M | 56 | 2 years | |
Ronald G. Tefteller | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Mark P. Mellin | M | 62 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
Victor Micati | M | 83 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Steven D. Weitman | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Joy Amundson | F | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 2 years |
Gary V. Woods | M | 80 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Joseph Bailes | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
Barclay Phillips | M | 61 | 2 years | |
Gregory Weaver | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
Chandra D. Lovejoy | F | 52 | 4 years | |
Jeffrey H. Buchalter | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
Timothy M. Ruane | M | 59 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
Craig Tooman | M | 58 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
Fred Cohen | M | 67 | 8 years | |
Michael McDonnell | M | 60 | 5 years | |
J. Edwards | M | 57 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 1 years |
Corey Levenson | M | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 8 years |
Lisa Benna | F | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 73 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Terry Murdock
- Personal Network